It is currently illegal to produce, sell or possess medical and recreational cannabis in Japan. THC-free products with hemp extracts derived from mature stalks and seeds are legal, as is CBD as long as it is synthetic or extracted from stalks/seeds.In the next few years, Japan could possibly open up to cannabis-derived medicines, cap THC content in hemp, and set universal parameters for licensing hemp cultivators. However, not all changes will be progressive, as the government is also considering criminalising the use of cannabis (as possession is already illegal) to tackle the increase in usage, especially among young people.
This report offers a detailed overview of Japan’s regulatory regime for cannabis, CBD and hemp, covering all policy areas and discussing future changes to the law.
Table of Contents
1 Executive Summary
2 Outlook
3 Hemp Plant
4 Extracts And Synthetics As Finished Products
5 Finished Products Containing CBD and Extracts
6 Import And Export Requirements
7 Minor Cannabinoids
8 Medical Cannabis
9 Recreational Cannabis
10 Relevant Laws
11 Relevant Bodies
Methodology
General Methodology/Sources
- Consumer and market participant (manufacturer/brand) surveys.
- Consolidation of publicly available information.
- Legal tracking through legal database checking and sourcing information from government regulators and other law-making bodies.
- Pricing and product information from online and offline retail data gathering, including local fieldwork teams.
- Findings from key industry events and interviews with leading market players and opinion leaders.
- Partnerships with leading research agencies.
- Quantitative and qualitative research and client collaborations.
- Cross-referenced data between markets.
- Tamarind Media proprietary market model.
Please note that each report has its own methodology, so you should always refer to the methodology applied in the report you purchase.
LOADING...
